Correlation Between Jasper Therapeutics and Minerva Neurosciences

Can any of the company-specific risk be diversified away by investing in both Jasper Therapeutics and Minerva Neurosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Jasper Therapeutics and Minerva Neurosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Jasper Therapeutics and Minerva Neurosciences, you can compare the effects of market volatilities on Jasper Therapeutics and Minerva Neurosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Jasper Therapeutics with a short position of Minerva Neurosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Jasper Therapeutics and Minerva Neurosciences.

Diversification Opportunities for Jasper Therapeutics and Minerva Neurosciences

-0.54

Correlation Coefficient

Jasper Therapeutics  Minerva Neurosciences

Excellent diversification

The 3 months correlation between Jasper and Minerva is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Jasper Therapeutics and Minerva Neurosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Minerva Neurosciences and Jasper Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Jasper Therapeutics are associated (or correlated) with Minerva Neurosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Minerva Neurosciences has no effect on the direction of Jasper Therapeutics i.e., Jasper Therapeutics and Minerva Neurosciences go up and down completely randomly.

Pair Corralation between Jasper Therapeutics and Minerva Neurosciences

Given the investment horizon of 90 days Jasper Therapeutics is expected to under-perform the Minerva Neurosciences. But the stock apears to be less risky and, when comparing its historical volatility, Jasper Therapeutics is 1.14 times less risky than Minerva Neurosciences. The stock trades about 0.0 of its potential returns per unit of risk. The Minerva Neurosciences is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  381.00  in Minerva Neurosciences on September 11, 2025 and sell it today you would earn a total of  9.00  from holding Minerva Neurosciences or generate 2.36% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Jasper Therapeutics  vs.  Minerva Neurosciences

Jasper Therapeutics

Risk-Adjusted Performance

Weakest

Over the last 90 days Jasper Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2026. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Minerva Neurosciences

Risk-Adjusted Performance

Fair

Compared to the overall equity markets, risk-adjusted returns on investments in Minerva Neurosciences are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Minerva Neurosciences showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Jasper Therapeutics and Minerva Neurosciences

The main advantage of trading using opposite Jasper Therapeutics and Minerva Neurosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Jasper Therapeutics position performs unexpectedly, Minerva Neurosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Minerva Neurosciences will offset losses from the drop in Minerva Neurosciences' long position.

The idea behind Jasper Therapeutics and Minerva Neurosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.